Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can an AI chatbot teach better sleep habits to young adults at risk?

NCT ID NCT05956886

Symptom relief Sponsor: University of Delaware Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 31, 2026 · Last updated Jul 31, 2026

Summary

This study explores whether an AI-powered chatbot can deliver personalized sleep coaching to Black/African American adults aged 18-25 who have poor sleep and at least one cardiometabolic risk factor. The chatbot uses principles of cognitive-behavioral therapy for insomnia (CBT-I) to set sleep goals and provide weekly guidance. Researchers will measure how acceptable and feasible the chatbot is, and whether it improves sleep quality, duration, and regularity. The goal is to see if this approach could offer a scalable way to address sleep problems in a group that often lacks tailored sleep interventions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
An artificial intelligence chatbot delivering cognitive-behavioral therapy for insomnia (CBT-I) principles, including sleep restriction and stimulus control, with personalized goal-setting and weekly behavioral prescriptions.
What this could lead to
If successful, this could lead to a scalable, culturally tailored digital tool to improve sleep and reduce cardiometabolic risk in young Black adults.
What could go wrong
This is a small feasibility study, so results may not generalize. The chatbot's effectiveness and long-term impact remain uncertain, and there are no guarantees it will outperform standard care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

26 people

The number who actually took part.

Started

Sep 2023

Finished

Feb 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 25 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * male or female ages 18-25 years old * self-identified as Black/African Americans (BAA), * poor sleep \[Insomnia severity index (ISI) \>10\] * having at least one of the cardiometabolic risk factors on the Life's Essential 8 checklist for cardiovascular health, as defined by the American Heart Association, including health factors confirmed by fasting blood testing during the first lab visit (fasting blood glucose ≥110mg/dL, high-density lipoprotein (good cholesterol) ≤ 40 mg/dL for males and ≤ 50 mg/dL for females, triglycerides ≥150mg/dL, total cholesterol ≥200 mg/dL, blood pressure ≥130/85mmHg, waist circumference≥40 inches for males, ≥35 inches for females) or healthy behaviors such as short sleep (\<7 hours), smoking or inactive (\<150 minutes/week of moderate aerobic activity such as gardening, social dancing, or \< 75 minutes/week of vigorous aerobic activity such as running, swimming laps, jumping rope), and (e) own a smartphone (iPhone or Android). * own a smartphone (iPhone or Android). Exclusion Criteria: * self-report medical conditions \[i.e., major depressive disorder \[Patient Health Questionnaire-9 (PHQ-9) ≥15) * diagnosed obstructive apnea\] that may affect sleep * regular use of medications with substantial impact on sleep and cardio-metabolic markers * shift worker * smoker * alcohol abuse (Alcohol Use Disorders Identification Test--short form score ≥7 for males and ≥5 for females) * self-report pregnancy/lactation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Insomnia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

abdominal obesity-metabolic syndrome insomnia metabolic syndrome X Sleep Deprivation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Insomnia Metabolic syndrome Sleep deprivation

Contacts and locations

Locations

  • University of Delaware

    Newark, Delaware, 19716, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.